Prestige Consumer Healthcare (PBH) Cash from Operations (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Cash from Operations came in at 78287000.0 in Q4 2025, up 20.27% year-on-year from 65091000.0 in Q4 2024, and up 36.18% quarter-over-quarter from 57486000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Cash from Operations (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Cash from Operations history runs 16 years deep, the most recent figure standing at 78287000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations rose 20.27% year-over-year to 78287000.0 in Q4 2025; TTM through Dec 2025 was 276634000.0, a 7.82% increase from a year earlier, with the FY2025 full-year figure at 251515000.0, up 1.04% from the prior year.
- Cash from Operations rose to 78287000.0 in Q4 2025 per PBH's latest filing, from 57486000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 79013000.0 in Q2 2025 and bottomed at 48087000.0 in Q2 2023.
- The 5-year median for Cash from Operations is 62154000.0 (2023), against an average of 63197600.0.
- Biggest YoY gain for Cash from Operations was 44.25% in 2025; the steepest drop was 17.64% in 2025.
- Year by year, Cash from Operations stood at 66297000.0 in 2021, then fell by 17.13% to 54942000.0 in 2022, then jumped by 30.09% to 71472000.0 in 2023, then declined by 8.93% to 65091000.0 in 2024, then grew by 20.27% to 78287000.0 in 2025.
- Per Business Quant, the three latest PBH Cash from Operations figures stand at 78287000.0 (Q4 2025), 57486000.0 (Q3 2025), and 79013000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 78.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78.29 Mn |
| Dec 31, 2025 | 78.29 Mn |
| Sep 30, 2025 | 57.49 Mn |
| Sep 30, 2025 | 57.49 Mn |
| Jun 30, 2025 | 79.01 Mn |
| Jun 30, 2025 | 79.01 Mn |
| Mar 31, 2025 | 61.85 Mn |
| Mar 31, 2025 | 61.85 Mn |
| Dec 31, 2024 | 65.09 Mn |
| Dec 31, 2024 | 65.09 Mn |
| Sep 30, 2024 | 69.80 Mn |
| Sep 30, 2024 | 69.80 Mn |
| Jun 30, 2024 | 54.78 Mn |
| Jun 30, 2024 | 54.78 Mn |
| Mar 31, 2024 | 66.91 Mn |
| Mar 31, 2024 | 66.91 Mn |
| Dec 31, 2023 | 71.47 Mn |
| Dec 31, 2023 | 71.47 Mn |
| Sep 30, 2023 | 62.46 Mn |
| Sep 30, 2023 | 62.46 Mn |